The HCC-Vec and -hGH cells were treated with a JAK2 inhibitor (AG490) to inhibit STAT3 activation, and the resulting effect on CLAUDIN-1 expression was determined. The gene discussed is CLDN7; the disease is hepatocellular carcinoma.